How do Addyi and Vyleesi compare side by side?
From the US Addyi and Vyleesi labels. Addyi figures are for premenopausal women; side-effect numbers come from different trials. The four rows above are the short version.
Show all 7 rowsHide table
| Addyi | Vyleesi | |
|---|---|---|
| Drug and form | Flibanserin 100 mg tablet1 | Bremelanotide 1.75 mg prefilled autoinjector2 |
| Approved for | Women under 65 with acquired, generalized HSDD; not for men or to enhance sexual performance1 | Premenopausal women with acquired, generalized HSDD; not for postmenopausal women or men, or to enhance sexual performance2 |
| How used | Once daily at bedtime, every day1 | As needed, at least 45 minutes before expected sexual activity; no more than one dose in 24 hours, and more than 8 a month is not recommended2 |
| If there is no improvement | Stopped after 8 weeks1 | Stopped after 8 weeks2 |
| Most common side effects in label trials | Dizziness 11.4% vs 2.2% on placebo, sleepiness 11.2% vs 2.9%, nausea 10.4% vs 3.9%1 | Nausea 40.0% vs 1.3% on placebo, flushing 20.3% vs 0.3%, headache 11.3% vs 1.9%2 |
| Stopped because of side effects | 13% vs 6% on placebo1 | 18% vs 2% on placebo2 |
| Boxed warning | Low blood pressure and fainting with alcohol, moderate or strong CYP3A4 inhibitors, or liver impairment1 | None2 |
Reviewed . Half-life figures are shown only where the value Dose Track uses agrees with the cited source.
What does the Addyi alcohol warning say?
Taking Addyi and alcohol close together raises the risk of severe low blood pressure and fainting. The boxed warning says to wait at least two hours after one or two standard drinks before the bedtime dose, to skip that night's dose after three or more drinks, and not to drink after the dose until the next day.1 In a study of Addyi taken at the same time as about two drinks, 4 of 23 healthy people (17%) had low blood pressure or fainting that needed treatment. Moderate or strong CYP3A4 inhibitors, including grapefruit juice, and any degree of liver impairment are also contraindicated for the same reason.1
How do the other warnings differ?
Addyi can cause sleepiness, and the label says to avoid driving or using machinery until at least 6 hours after a dose. It is taken at bedtime because daytime dosing raises the risk of low blood pressure, fainting and sleepiness.1 Each Vyleesi dose briefly raises blood pressure, by up to 6 mmHg systolic, with a peak 2 to 4 hours after the dose, so it is not used with uncontrolled high blood pressure or known heart disease. Its label also lists skin darkening on the face, gums or breasts (1% with up to 8 doses a month), and nausea that was most common after the first dose: 21% then, about 3% after later doses.2 These numbers come from separate trials with different people, lengths and methods, so they are not a head-to-head comparison.
Which, if either, fits is for your prescriber. More detail: Addyi side effects, Vyleesi side effects, the Addyi and Vyleesi dosing schedules, and the Addyi missed-dose page.
Frequently asked questions
Can Addyi or Vyleesi be used after menopause?
Can I drink alcohol with Addyi?
The boxed warning says to wait at least two hours after one or two standard drinks before the bedtime dose, skip that night's dose after three or more drinks, and not drink after the dose until the next day.1
What if I miss a dose?
Can Dose Track remind me to take them?
Yes. You can log each dose and set a reminder.
Related comparisons
- PT-141 vs Melanotan II: how do they differ?FDA-labeled bremelanotide vs its unapproved parent
- Osphena vs Intrarosa: how do the pill and the vaginal insert differ?Daily tablet vs nightly vaginal insert
- Estrace Cream vs Vagifem: how do the two vaginal estradiol products differ?Estradiol cream vs 10 mcg estradiol insert
- Free reconstitution calculatorVial strength and water to syringe units
See also
Sources
- Addyi (flibanserin) tablets prescribing information and Medication Guide, boxed warning and sections 1, 2, 4, 5 and 6. DailyMed, version of December 23, 2025.
- Vyleesi (bremelanotide injection) prescribing information and Patient Information, sections 1, 2, 4, 5 and 6. DailyMed, version of November 18, 2025.
All compound comparisons · All compound guides · Peptide tracking in Dose Track